BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38184947)

  • 1. Discovery of 1,2,3-triazole incorporated indole-piperazines as potent antitubercular agents: Design, synthesis, in vitro biological evaluation, molecular docking and ADME studies.
    Reddyrajula R; Etikyala U; Manga V; Kumar Dalimba U
    Bioorg Med Chem; 2024 Jan; 98():117562. PubMed ID: 38184947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies.
    Reddyrajula R; Dalimba U; Madan Kumar S
    Eur J Med Chem; 2019 Apr; 168():263-282. PubMed ID: 30822714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles.
    Reddyrajula R; Dalimba U
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126846. PubMed ID: 31839540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
    Patil PS; Kasare SL; Haval NB; Khedkar VM; Dixit PP; Rekha EM; Sriram D; Haval KP
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127434. PubMed ID: 32717369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, biological screening and molecular docking studies of novel multifunctional 1,4-di (aryl/heteroaryl) substituted piperazine derivatives as potential antitubercular and antimicrobial agents.
    Mekonnen Sanka B; Mamo Tadesse D; Teju Bedada E; Mengesha ET; Babu G N
    Bioorg Chem; 2022 Feb; 119():105568. PubMed ID: 34968884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Chem Biol Drug Des; 2021 Jun; 97(6):1137-1150. PubMed ID: 33638304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
    Soares A; Estevao MS; Marques MMB; Kovalishyn V; Latino DARS; Aires-de-Sousa J; Ramos J; Viveiros M; Martins F
    Med Chem; 2017; 13(5):439-447. PubMed ID: 28185538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis.
    Rode ND; Sonawane AD; Nawale L; Khedkar VM; Joshi RA; Likhite AP; Sarkar D; Joshi RR
    Chem Biol Drug Des; 2017 Dec; 90(6):1206-1214. PubMed ID: 28609019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of new indanol-1,2,3-triazole derivatives as potent antitubercular and antimicrobial agents.
    Phatak PS; Bakale RD; Kulkarni RS; Dhumal ST; Dixit PP; Krishna VS; Sriram D; Khedkar VM; Haval KP
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127579. PubMed ID: 32987135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues.
    Nandikolla A; Mahadu Khetmalis Y; Mahalakshmi Naidu K; Karan Kumar B; Murugesan S; Chandra Sekhar KVG
    Toxicol In Vitro; 2022 Aug; 82():105370. PubMed ID: 35489549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3-Triazoles: A Computational Docking Techniques.
    Sadineni K; Reddy Basireddy S; Rao Allaka T; Yatam S; Bhoomandla S; Muvvala V; Babu Haridasyam S
    Chem Biodivers; 2024 May; 21(5):e202400389. PubMed ID: 38457745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
    Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
    Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents.
    Munnaluri RK; Chevula J; Patnam N; Yamini L; Manga V
    Indian J Tuberc; 2023 Oct; 70(4):451-459. PubMed ID: 37968051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.
    Pradeep Kumar CB; Prathibha BS; Prasad KNN; Raghu MS; Prashanth MK; Jayanna BK; Alharthi FA; Chandrasekhar S; Revanasiddappa HD; Yogesh Kumar K
    Bioorg Med Chem Lett; 2021 Mar; 36():127810. PubMed ID: 33482292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
    Ramprasad J; Nayak N; Dalimba U
    Eur J Med Chem; 2015 Dec; 106():75-84. PubMed ID: 26520841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
    Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel furan-based chalcone derivatives as anti-tuberculosis agents:
    Dhivya LS; Kumaradoss KM
    Future Med Chem; 2023 Sep; 15(18):1687-1701. PubMed ID: 37732414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.